Position in NVO
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$88,257
+$20,601 QoQ
Shares Held
1,841
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,079
of 1,347 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Derivatives in NVO
reported options exposure · as of Jun 30, 2026CallValue
$23,970
CallShares
500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HOLLENCREST CAPITAL MANAGEMENT holds $5,976,653 across 13 Drug Manufacturers - General names. NVO ranks #7 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
4,074 | $1,475,276 | |
| 2 | ABBV |
AbbVie Inc.
|
5,785 | $1,455,737 | |
| 3 | JNJ |
Johnson & Johnson
|
4,993 | $1,268,072 | |
| 4 | LLY |
ELI LILLY & Co
|
768 | $921,162 | |
| 5 | MRK |
Merck & Co., Inc.
|
4,878 | $626,823 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
744 | $93,996 | |
| 7 | NVO |
Novo Nordisk A S
This page
|
1,841 | $88,257 | |
| 8 | PFE |
Pfizer Inc
|
881 | $21,214 |
All Filings in NVO
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $88,257 | 1,841 | Shares | Sole | 2026-08-13 | |
| 2026-06-30 | $23,970 | 500 | Call | Sole | 2026-08-13 | |
| 2026-03-31 | $18,375 | 500 | Call | Sole | 2026-05-07 | |
| 2026-03-31 | $67,656 | 1,841 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $146,941 | 2,888 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $167,968 | 3,027 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $297,131 | 4,305 | Shares | Sole | 2025-08-18 | |
| 2025-03-31 | $298,939 | 4,305 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $391,907 | 4,556 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $581,180 | 4,881 | Shares | Sole | 2024-11-01 | |
| 2024-09-30 | $238,140 | 2,000 | Call | Sole | 2024-11-01 | |
| 2024-06-30 | $838,882 | 5,877 | Shares | Sole | 2024-08-13 | |
| 2024-06-30 | $14,274 | 100 | Call | Sole | 2024-08-13 | |
| 2024-03-31 | $899,955 | 7,009 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $622,769 | 6,020 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $542,366 | 5,964 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $391,143 | 2,417 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $324,963 | 2,042 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $277,988 | 2,054 | Shares | Sole | 2023-02-07 | |
| No filing history on record for this holder in this stock. | ||||||